Industry Sponsored Satellite Symposia
(Companies in alphabetical order)
AbbVie Deutschland GmbH (Platin Circle Member)
Satellite Symposium I: Sunday, March 19, 2023 – 16.30-17.30 (Lecture Hall III)
“Transforming the AML Treatment Paradigm: An Expert Conversation”
Welcome and Introduction
H. Döhner, Ulm, DE
Changing Foundations in AML Treatment
G. Roboz, New York, NY, USA
Building on New Treatment Approaches
Ch. Craddock, Birmingham, UK
Panel Discussion and Q&A
All Faculty
Closing Remarks
H. Döhner, Ulm, DE
Bristol Myers Squibb (Platin Circle Member)
Satellite Symposium IIII: Monday, March 20, 2023 – 18:00-19:00 (Lecture Hall III)
“Maintenance in AML: How far Have we Come and Where are we Headed?”
Welcome and Introduction
Gail JH. Roboz (Chair)
Weill Cornell Medical College New York, NY, USA
How do I Maintain Remission in Patients with AML?
Klaus H. Metzeler University Hospital Leipzig Germany
Thomas Cluzeau University Hospital of Nice France
Q & A and Closing Remarks
Gail J. Roboz, Klaus H. Metzeler, and Thomas Cluzeau
Jazz Pharmaceuticals. (Gold Circle Member)
Satellite Symposium IV: TUESDAY, March21,2023 – 16:00-17:00
“Evidence-Based Practice for High-Risk AML: Classifications, Clinical Studies, and the Real World”
Welcome and Introduction
L. Bullinger, Berlin, DE
High-Risk AML in 2023 – Have our New Classifications Improved our Management of Patients?
L. Bullinger, Berlin, DE
From Clinical Trials to the Clinic: Why Real-World Evidence Matters.
A. Venditti, Rome, I
Case Study Debate: Integrating Knowledge from Clinical Studies and Real-World Evidence
Th. Schroeder, Essen, DE
Audience: Q&A
Close
L. Bullinger, Berlin, DE
Pfizer GmbH (Gold Circle Member)
Satellite Symposium II: Monday, March 20, 2023 – 12:45-13:45 (Lecture Hall III)
“Targeted treatment in ALL and AML”
M. Subklewe, Munich, DE
R. Wäsch, Freiburg, DE